Daily Top 50 Gainers & Losers

Market Regime — the colored bar under each day is the market's overall “weather,” scored from the indexes (trend, fear/VIX, small-cap breadth). It's market-wide context, not a stock pick: even a great company gets dragged down in a red tape. Read it to gauge when to lean in vs. wait for calmer water — click any day for the full read.

Risk-On · supportive Neutral Risk-Off · headwind Stress · fear

Market Recap · Thursday, September 10, 2026

Snapshot: Sep 10, 2026 · 6:00 PM 100 stocks analyzed

Down Day

Thu, Sep 10, 2026 Risk-Off High

Fear spiked 23% as broad selloff engulfed equities on September 10, with Russell 2000 leading losses and dispersion extreme across 50 top movers on each side.

60% VIX surged 22.8% to 17.84 amid a risk-off selloff that pulled S&P 500 down 0.98%, Russell 2000 down 2.11%, and Dow down 1.88%, signaling a shift from complacency to measurable fear despite moderate index declines. Market regime was textbook risk_off with high dispersion, reflecting broad sector capitulation and unease rather than targeted repricing.
25% Dispersion ran extreme with 50 gainers averaging +24.5% and 50 losers averaging -24.9%, anchored by outliers like ZVZZT (+85%), DBGI (+85% on go-private news), and GPAC (-98%), indicating wild single-stock moves rather than orderly sector rotation. Healthcare dominated both gainers (28% of top 50) and losers (25% of top 50), signaling confusion and two-way flows in that sector.
15% News-grounded catalysts proved decisive: ACVA surged 41% on Copart's $1.9 billion acquisition; SKIL crashed 33% despite beating earnings due to AI disruption guidance; BHVN fell 14.8% on FDA clinical hold; and LAKE dropped 13.7% on goodwill impairment—underscoring that when earnings or regulatory news broke, it drove moves regardless of broad market direction.

5 names returned after long absences WTER · 3-day gainers streak INDP · 3-day gainers streak UYSCR — first appearance NFE — first appearance

Market Regime

Thu, Sep 10, 2026 Risk-Off conf: medium macro · prototype

-32

Headwind −100 … +100 · + tailwind / − headwind

VIX17.8 p76 Drawdown-2.7% Held1d · nascent SinceSep 10

Top drivers: VIX percentile ▼ VIX 5d momentum ▼ Small-cap leadership ▼

processId: history-market-regime

Market Indexes

Thu, Sep 10, 2026 13

S&P 500

7,591.70

−74.90

-0.98%

Dow Jones

52,064.10

−997.85

-1.88%

NASDAQ Composite

26,081.73

−136.11

-0.52%

NASDAQ 100

29,103.51

−39.82

-0.14%

DJ US Total Market

74,994.69

−775.80

-1.02%

Russell 1000

4,131.38

−42.19

-1.01%

S&P MidCap 400

3,683.64

−62.80

-1.68%

Russell 2000

2,890.95

−62.22

-2.11%

Russell 2500

1,234.47

−12.13

-0.97%

Russell 3000

4,308.75

−45.98

-1.06%

Nasdaq Financial-100

7,571.53

−32.76

-0.43%

NIFTY 50

23,477.80

−419.90

-1.76%

VIX

17.84

+3.31

+22.78%

Biggest Gainers

Thu, Sep 10, 2026 50

ZVZZT

$30.06+$13.81

+84.9%

DBGI

Digital Brands Group, Inc.Consumer Cyclical

$6.74+$3.14

+84.9%

NASDAQ · Mkt cap $6.8 M

Digital Brands Group announced an investor update on a U.S. program and go-private process with timeline, likely triggering the 84.86% surge as investors react to potential delisting and restructuring plans.

The headline references an investor update covering a U.S. program and a go-private process with timeline, but the full text is truncated and does not provide specific details about valuation, offer price, or transaction structure. An 84.86% single-day gain on a go-private announcement typically suggests either the implied offer price is substantially above the pre-announcement market price, the market was pricing in a lower probability of the transaction completing, or investors view the delisting as value-accretive. The fact that this is ranked the second-biggest gainer on the day indicates broad market participation in the move. Without access to the complete announcement details, the specific mechanics of the go-private process and the offer price relative to recent trading levels remain unclear, limiting confidence in the exact valuation rationale.

TNON

Tenon Medical, Inc.Healthcare

$5.32+$2.19

+72.5%

NASDAQ · Mkt cap $2.4 M

Tenon Medical announced early repayment of convertible notes on September 9, a proactive balance-sheet move that likely triggered the 72% gain by removing dilution risk and signaling financial confidence.

The company announced early repayment of its convertible notes, framing this as a step to strengthen its balance sheet and maintain flexibility for business execution. This type of announcement typically appeals to equity investors because it eliminates future dilution from note conversion, reduces leverage, and signals management confidence in the business. Early repayment requires either available cash or refinancing capacity, both of which suggest improving financial health or operational performance. The headline explicitly ties the action to "continued business momentum," implying positive underlying fundamentals. However, the news snippet is truncated and does not provide details on the repayment amount, timing, or specific financial metrics that might independently justify such a large move, so some of the surge may reflect broader positive sentiment or technical factors in a small-cap stock.

WTER

Alkaline Water Co Inc-TheConsumer Defensive

$0.04+$0.01

+45.8%

NASDAQ · Mkt cap $1.1 M

No news headlines were published in the last 48 hours, so the 45.83% gain likely reflects technical or market-driven factors typical of low-priced microcap stocks rather than a company-specific catalyst.

The absence of recent news headlines means we cannot attribute this jump to earnings, guidance, product announcements, regulatory actions, or M&A activity. WTER trades at $0.04, making it a penny stock with characteristically high volatility and thin liquidity. Moves of this magnitude in microcaps typically stem from short-covering, retail investor sentiment shifts, technical breakouts on minimal volume, delayed news digestion, or sector rotation rather than fundamental company developments. Without access to intraday volume data, social media activity, or any corporate disclosure, identifying the specific mechanism behind today's spike is not possible from the evidence provided.

AHMA

Ambitions Enterprise Management Co. L.L.CConsumer Cyclical

$1.76+$0.53

+42.8%

ACVA

ACV Auctions Inc.Consumer Cyclical

$7.23+$3.03

+41.1%

OCUP

Ocuphire Pharma, Inc.

$6.07+$1.73

+39.7%

FSHPR

Flag Ship Acquisition Corporation

$0.10+$0.03

+38.1%

NASDAQ

No headlines were found in the last 48 hours, so the cause of the 38.12% gain cannot be determined from news. The move likely reflects technical trading, a delayed announcement, or sentiment shift in a micro-cap SPAC.

Flag Ship Acquisition Corporation (FSHPR) jumped 38 percent with no corresponding news headlines in the preceding 48 hours. This absence of news coverage is notable for a top-ten gainer. For a blank-check company trading at $0.10, possible catalysts include a delayed press release or investor announcement not yet picked up by Yahoo Finance RSS feeds, technical buying in a low-priced micro-cap stock, short covering in a thinly traded security, or retail trading attention. SPACs in pre-merger or merger-negotiation phases are historically sensitive to rumors and sentiment shifts even absent formal disclosure. Without access to company filings, press releases, or social media activity, we cannot determine whether this reflects genuine corporate development or market dynamics in a low-liquidity security.

UYSCR

UY Scuti Acquisition Corp.

$0.10+$0.03

+33.3%

HEPA

Hepion Pharmaceuticals IncHealthcare

$0.08+$0.02

+32.0%

NASDAQ · Mkt cap $5.5 M

No news headlines were available in the last 48 hours, so the 32% gain likely reflects technical trading, sector momentum, or untracked corporate developments specific to this small-cap biotech company.

Hepion Pharmaceuticals is a micro-cap biotech stock trading at $0.08, and the absence of any Yahoo Finance headlines in the prior 48 hours means we cannot point to a specific catalyst such as a trial result, FDA action, financing announcement, or guidance change. For penny stocks and small biotech firms, price moves of this magnitude can occur from several sources: short covering in a heavily shorted name, retail momentum or social media activity, sector-wide biotech rallies that aren't individually tracked in major news feeds, or internal corporate announcements that may have been released through investor relations channels but not yet indexed by major news aggregators. Without direct evidence of news, the move remains unexplained by publicly available headline data.

AEON

AEON Biopharma, Inc.Healthcare

$0.30+$0.07

+28.2%

NYSE · Mkt cap $9.9 M

AEON surged 28% on positive pilot data for ABP-450, a biosimilar to BOTOX, showing comparable degradation rates and oxidation patterns that support analytical comparability claims.

On September 9, AEON announced results from a forced degradation study of ABP-450, its proposed biosimilar to BOTOX (botulinum toxin). The pilot data demonstrated that ABP-450 and the reference BOTOX product exhibited comparable rates of potency loss under thermal stress and similar site-specific oxidation patterns at methionine sites. This is a substantive analytical milestone because it supports the company's analytical comparability case, which is a critical regulatory pathway for biosimilar approval by the FDA. The 28% single-day gain suggests investors viewed this as meaningful de-risking of the development program, reducing uncertainty about whether ABP-450 will clear the analytical comparability hurdle required before clinical studies can proceed toward an FDA submission.

PSIG

PS International Group Ltd. Ordinary SharesIndustrials

$2.27+$0.49

+27.2%

NASDAQ · Mkt cap $31 M

No news was published in the last 48 hours about PSIG, so the 27% gain cannot be attributed to a disclosed catalyst. The jump likely stems from technical, sentiment-driven, or undisclosed developments.

The absence of recent headlines from Yahoo Finance is notable given the magnitude of the move—a 27% single-day gain typically correlates with material news, earnings surprises, or significant corporate actions. For a small-cap stock like PSIG trading near $2.27, possible explanations include short covering or a momentum squeeze if the stock had been oversold or heavily shorted, renewed retail interest following a period of neglect, or an unannounced development that has not yet reached mainstream financial media. Without access to company filings, social media activity, or alternative news sources beyond the provided Yahoo Finance RSS feed, we cannot identify the specific trigger. The timing of the jump—ranking 12th among daily gainers—suggests it was real market movement rather than a data error, but the cause remains opaque.

CAPNR

Cayson Acquisition Corp Right

$0.11+$0.02

+25.7%

BYSI

Beyondspring IncHealthcare

$0.77+$0.16

+25.6%

NASDAQ · Mkt cap $30 M

No news headlines were available in the last 48 hours, so the 25.61% gain cannot be directly attributed to a reported event. The move is likely driven by technical factors, market sentiment, or unannounced company developments.

Beyondspring Inc experienced a significant single-day jump of over 25 percent with no corresponding news coverage appearing in the financial headlines monitored over the past two days. This disconnect between price action and public information suggests several possible explanations. For a small-cap biotech or pharmaceutical company like Beyondspring, catalysts often include clinical trial results, regulatory submissions or approvals, partnership announcements, or insider transactions that may not immediately appear in major RSS feeds. Alternatively, the move could reflect technical buying pressure, short-covering activity, or broader market sentiment shifts in the biotech sector. Without headline confirmation, we cannot determine which factor drove the rally, though biotech stocks of this market cap are known to be volatile and responsive to clinical or regulatory news that breaks unevenly across news sources.

INDP

Indaptus Therapeutics, Inc.Healthcare

$2.57+$0.51

+24.8%

NASDAQ · Mkt cap $125 M

No news headlines were found in the last 48 hours, so the 24.76% gain likely reflects either a delayed market reaction to an earlier announcement, technical trading activity, or untracked developments in the biotech sector.

The absence of recent news headlines makes it difficult to pinpoint a specific catalyst for Indaptus Therapeutics' sharp 24.76% gain on September 10, 2026. For a small-cap biotech company like INDP, price movements of this magnitude are sometimes driven by clinical trial results, regulatory announcements, partnership news, or shifts in investor sentiment that may not appear immediately in major news feeds. Alternatively, this could represent technical momentum, short covering, or a delayed market reaction to information released outside the 48-hour window captured here. Without confirming headlines, we cannot establish a news-grounded explanation.

SKYQ

Sky Quarry Inc.Energy

$3.17+$0.65

+23.9%

NASDAQ · Mkt cap $12 M

No headlines were found in the last 48 hours, so the 23.93% jump in SKYQ cannot be attributed to published news. The move was likely driven by a delayed announcement, technical trading, or market rumors not yet covered by major outlets.

The absence of any news headlines in the last 48 hours despite a strong 23.93% single-day gain is notable. This suggests the catalyst either occurred before the search window, was not picked up by Yahoo Finance RSS feeds, or was driven by factors other than traditional corporate announcements. For a small-cap NASDAQ stock like Sky Quarry Inc., significant single-day moves without visible news often reflect short-squeeze activity, sector rotation, insider trading hints, social media attention, or delayed coverage of earlier developments. Without access to the specific business model or float structure of SKYQ, it is not possible to narrow this further.

FEIM

Frequency Electronics IncTechnology

$61.94+$14.86

+23.4%

NASDAQ · Mkt cap $669 M

Frequency Electronics reported record quarterly revenue of $23.5 million (up 70% year-over-year) and a record $129 million funded backlog (up 82% year-over-year), driving the 23.35% gain on strong operating leverage demonstration.

The headline announces first-quarter fiscal 2027 results with material top-line and backlog beats. Revenue grew 70% year-over-year and 52% sequentially to a record $23.5 million, while the funded backlog reached $129 million, up 82% year-over-year. The headline explicitly notes strong operating leverage, which typically signals expanding margins ahead. For a smaller-cap precision electronics company like Frequency Electronics, this combination of accelerating growth, record backlog, and operating leverage signals either newfound market demand or successful execution on existing contracts. The backlog growth particularly matters because it provides visibility into future revenue. The magnitude of the moves (70% revenue growth, 82% backlog growth) is substantial enough to justify an equity-market response in the 20% range, especially if prior guidance or analyst expectations were more modest.

ATER

Aterian, Inc.Consumer Cyclical

$0.86+$0.16

+22.3%

NFE

New Fortress Energy LLC

$0.33+$0.06

+22.0%

WTGUR

Wintergreen Acquisition Corp. Rights

$0.17+$0.03

+21.4%

NASDAQ

No news headlines were found in the last 48 hours, but WTGUR is a SPAC rights offering security which typically exhibits high volatility and can move sharply on technical factors, redemption activity, or warrant/share conversion events.

No recent news was available to explain today's 21.43% gain for Wintergreen Acquisition Corp. Rights. However, WTGUR's structure as a rights instrument linked to a SPAC warrant or share redemption offers a plausible framework for the move. Rights offerings associated with SPAC mergers or extensions often experience sharp intraday swings driven by (1) changes in the underlying SPAC's merger timeline or valuation expectations, (2) shifts in redemption ratios or exercise mechanics, or (3) technical trading around support/resistance levels given the illiquid nature of individual rights. The stock's position as the 20 gainer on modest absolute price movement ($0.17) suggests either very light trading volume or a gap up opening. Without specific news, the catalyst remains unknown, though SPAC-related rights typically respond to corporate actions, redemption announcements, or implied volatility changes rather than broader market sentiment.

SLXN

Biomotion SciencesHealthcare

$0.42+$0.07

+20.5%

NASDAQ · Mkt cap $540 K

Silexion Therapeutics announced participation in September 2026 industry and investor conferences; the modest newsflow and 20.52% single-day jump suggests investor anticipation of upcoming presentations or commentary, though the headline alone does not establish a specific catalyst.

The only headline provided is a conference participation announcement from September 9, 2026, which is routine corporate disclosure for clinical-stage biotech firms. Such announcements typically do not drive a 20% intraday move on their own. The timing and magnitude of this gain suggest either (1) market anticipation that the company will present positive clinical or operational updates at these conferences, or (2) short covering or technical momentum in a thinly traded micro-cap stock where volume and float constraints can amplify price moves. Clinical-stage RNAi therapeutics companies often trade on binary clinical trial outcomes or partnership news, neither of which are explicitly mentioned in the provided headlines. The jump could also reflect delayed market reaction to an earlier event or general sector momentum.

TRAD.UN

$12.40+$2.09

+20.3%

TANH

Tantech Holdings LtdConsumer Defensive

$23.89+$3.99

+20.1%

NASDAQ · Mkt cap $5.6 M

No news headlines were found in the last 48 hours, so the 20% gain on TANH cannot be directly attributed to a named corporate event or public announcement. The move likely reflects technical momentum, delayed market reaction to earlier news, or retail trading activity.

The absence of recent headlines for a stock jumping 20% to rank as the 23rd biggest gainer creates an explanatory gap. For micro-cap or lower-liquidity securities like Tantech Holdings, large single-day moves sometimes reflect technical factors such as short covering, options-driven gamma effects, or delayed dissemination of news that broke before the snapshot window. Alternatively, the catalyst could be an intra-day rumor, broker upgrade, or sector rotation into Chinese manufacturing or materials stocks (Tantech's sector). Without access to pre-market activity, Level 2 data, or news from earlier in the week, we cannot pinpoint the specific event driving the rally.

NSAIR

NorthStrive Acquisition Corp I. Rights

$0.17+$0.03

+20.0%

CMRC

BigCommerce Holdings, Inc. - Series 1Technology

$3.10+$0.49

+18.8%

NASDAQ · Mkt cap $178 M

BigCommerce announced a strategic operating plan targeting $60–80 million in annual cost savings and a non-GAAP operating margin of at least 20% by 2027, driving an 18.78% stock gain as investors respond positively to improved profitability guidance.

The two headlines from September 10 describe the same announcement: BigCommerce's strategic plan to achieve material cost reductions and accelerated profitability. The company is committing to annualized cost savings between $60–80 million and targeting non-GAAP operating margins of at least 20% beginning in 2027, coupled with materially higher free cash flow generation. For a SaaS or commerce platform company, such concrete cost-reduction and margin expansion targets typically signal management confidence in operational efficiency and improved unit economics. Investors generally reward this type of guidance positively because it addresses profitability concerns and suggests a clearer path to sustainable cash generation. The timing and specificity of the targets appear to have resonated with the market, placing CMRC among the day's top 25 gainers.

REBN

Reborn Coffee, Inc.Consumer Cyclical

$0.83+$0.13

+18.4%

NASDAQ · Mkt cap $12 M

No news headlines were available in the last 48 hours to explain the 18.4% gain, so the driver remains unclear. Generic microcap catalysts such as technical rebounds, delayed announcements, or social media chatter are possible but unconfirmed.

The absence of any news in the provided RSS feed means we cannot identify a specific catalyst for Reborn Coffee's strong performance today. Microcap stocks like REBN, trading below $1, often exhibit outsized moves on minimal volume and are susceptible to several alternative drivers: a delayed earnings release or guidance revision that has not yet appeared in headline aggregators, a short squeeze or technical bounce off support, retail investor interest via social platforms, or even a rumor circulating in penny-stock forums. Without additional information about the stock's float, short interest, or recent chart activity, or confirmation of any corporate announcement, any explanation would be pure speculation.

KRSP.WT

$1.05+$0.16

+18.0%

TPET

Trio Petroleum Corp. Common StockEnergy

$2.04+$0.31

+16.8%

NYSE · Mkt cap $9.1 M

No news headlines appeared in the last 48 hours, so the 16.76% gain cannot be attributed to a disclosed catalyst. The move likely reflects either a technical bounce, delayed market reaction to an earlier announcement, or market sentiment in the oil and gas sector.

The absence of any news in the Yahoo Finance RSS feed over the past two days makes it impossible to tie TPET's strong gain to a specific corporate event. For a small-cap energy stock like Trio Petroleum, intraday rallies of this magnitude can stem from several sources: technical oversold conditions triggering a short covering or momentum reversal, delayed market digestion of older earnings or operational updates, sector-wide moves in crude oil prices or energy sentiment, or retail trading interest. Without access to intraday data, trading volumes, or news from other sources, we cannot determine which driver was operative. The energy sector as a whole experiences significant volatility tied to commodity prices, so a broader crude rally could have lifted TPET alongside peers.

GBR

New Concept Energy Inc

$0.80+$0.12

+16.1%

WLTH

LifeGoal Wealth Builder ETF

$10.90+$1.51

+16.0%

SUMAR

SUMA Acquisition Corporation Rights

$0.26+$0.04

+15.9%

SURG

Surge Holdings, Inc.Communication Services

$0.16+$0.03

+15.8%

NASDAQ

SurgePays announced the sale of its ClearLine Apps Engagement Platform for $27.5 million, a material asset divestiture that likely triggered the 15.83% gain as markets view it as a strategic capital-raising move or business repositioning.

The headline establishes a concrete M&A event: SurgePays sold ClearLine Apps (which includes a prepaid wireless company and managed marketing services platform) for $27.5 million in consideration. For a micro-cap fintech trading at $0.16, a $27.5 million transaction represents substantial capital inflow or liability relief relative to likely market cap. The market's positive reaction suggests investors either (1) view the divestiture price as favorable relative to embedded value, (2) see the freed capital as enabling debt paydown or strategic reinvestment, or (3) interpret the sale as a pivot away from underperforming assets toward higher-return business lines. The headline does not specify cash terms, debt forgiveness, earn-out structures, or use of proceeds, which limits certainty about whether this is accretive or merely balance-sheet neutral.

EHLD

Euroholdings Ltd.Industrials

$15.24+$2.17

+15.8%

NASDAQ · Mkt cap $27 M

Euroholdings announced a $0.14 per share dividend with ex-dividend date on 2026-09-09, likely triggering the 15.80% gain as investors positioned ahead of or reacted positively to the income distribution.

The only headline provided is a dividend announcement from Euroholdings on 2026-09-09, stating a $0.14 per share dividend payment with that same date as the ex-dividend date. While dividend announcements can attract income-focused investors, a 15.80% single-day jump is substantially larger than typical dividend yield support alone would explain. A $0.14 dividend on a $15.24 stock represents roughly 0.92% annualized yield, which does not justify a 15% move. The timing is plausible—the ex-dividend date coincides with the snapshot date—but the magnitude of the move suggests either the market is pricing in additional positive catalysts not mentioned in the headlines, or there is other news not captured in this RSS feed. Without additional context about the company's business performance, guidance, or market conditions, the full explanation remains incomplete.

ZSTK

ZeroStack Corp.Financial Services

$4.84+$0.66

+15.8%

NASDAQ · Mkt cap $32 M

No news headlines were published about ZSTK in the last 48 hours, so the 15.79% gain likely reflects technical trading, a delayed announcement, or market speculation rather than a confirmed catalyst.

The absence of recent news headlines makes it difficult to pinpoint a specific catalyst for the 15.79% jump. ZSTK is a relatively small-cap stock trading at $4.84, which means it can be more susceptible to technical momentum, short-covering, or retail trading activity than large-cap peers. Possible drivers in this category include oversold bounce-back following prior weakness, positive sentiment from a broader market or sector rally, or a delayed earnings or product announcement that may not yet have reached Yahoo Finance feeds. Without headline confirmation, we cannot rule out that the move was driven by intraday momentum, options expiration effects, or unverified rumors. A deeper look at the company's fundamentals, recent earnings dates, and insider transactions would be needed to narrow this down.

ZIVO

Zivo Bioscience, Inc.Healthcare

$3.60+$0.49

+15.8%

NASDAQ · Mkt cap $17 M

No news headlines were available in the last 48 hours to explain ZIVO's 15.76% gain, so the catalyst remains unknown; biotech stocks of this size often spike on clinical trial results, partnership announcements, or short covering.

Yahoo Finance returned no headlines for ZIVO in the past 48 hours, making it impossible to attribute the move to a specific announced event. ZIVO is a small-cap biotech company, and stocks in this category are prone to sharp single-day moves driven by clinical trial announcements, FDA decisions, licensing deals, or strategic partnerships that may not immediately appear in major news aggregators or may be disclosed through press releases on the company's investor relations site rather than broad media. Another possibility common to thinly traded small-cap biotechs is short covering or retail momentum trading, particularly if the stock had been shorted or was trending on social platforms. Without access to the company's own disclosures or detailed intraday volume data, any explanation is speculative.

BURUD

NUBURU INC

$1.94+$0.26

+15.5%

CRDF

Cardiff Oncology, Inc.Healthcare

$1.22+$0.16

+15.2%

NASDAQ · Mkt cap $70 M

No news headlines were found in the last 48 hours, so the 15.17% gain likely reflects a technical rebound, delayed reaction to earlier news, or sector-wide movement in oncology stocks rather than a company-specific catalyst.

The absence of recent headlines in the search results makes it difficult to pinpoint a direct cause for Cardiff Oncology's sharp one-day gain. As a small-cap oncology biotech stock trading at $1.22, CRDF is the type of security that can experience significant intraday volatility on modest volume, reversal trades following oversold conditions, or delayed market reaction to clinical trial announcements or regulatory developments that may not have been immediately picked up in the Yahoo Finance RSS feed. It is also possible the move reflects sector rotation into biotech names or a reversal of prior-week selling pressure. Without access to company press releases, SEC filings, or clinical trial updates from the past several days, we cannot identify a specific catalyst beyond speculating on typical drivers for this asset class.

SEGG

Lottery.com, Inc.Consumer Cyclical

$3.03+$0.39

+14.3%

NASDAQ · Mkt cap $8.4 M

No news headlines were found in the last 48 hours for SEGG, so the 14.29% gain cannot be attributed to a specific announced event. The move is likely driven by technical factors, retail trading activity, or untracked news on social media or forums.

Lottery.com is a micro-cap stock trading on NASDAQ with a history of high volatility and retail investor interest. In the absence of identified news catalysts, the significant single-day gain most likely reflects either technical chart-based buying (breakout, support bounce, or short covering), social media chatter or forum activity not captured in mainstream financial news feeds, or general retail momentum in small-cap lottery and gaming-adjacent names. Micro-cap stocks in this space are known to exhibit outsized moves on low volume and thin liquidity. Without headlines or SEC filings dated around the snapshot, attributing this move to a specific corporate event is not supported by the provided evidence.

DBI

Designer Brands IncConsumer Cyclical

$5.98+$0.73

+13.9%

NYSE · Mkt cap $311 M

Designer Brands raised full-year EPS guidance to $0.47–$0.52 on better-than-expected Q2 earnings, posting 430 basis points of gross margin expansion and 18% brand portfolio sales growth, driving the 13.90% gain.

Designer Brands reported Q2 adjusted earnings that beat analyst estimates and raised full-year profit guidance the same day. The earnings call highlights underscore two key drivers: gross margin expanded significantly by 430 basis points despite a 2.4% comparable sales decline, and brand portfolio sales jumped 18%, indicating strong mix and operational leverage. The company also signaled an upbeat start to Q3. While headline revenue declined 1.2%, the guidance raise and margin beat appear to have reassured investors that profitability and cash generation are accelerating even as comp sales remain under pressure. The simultaneous announcement of a new "The Edit" concept pilot in four DSW locations adds a forward-looking growth narrative. The combination of beat, raise, and margin expansion justified a +13.90% move.

NWAX.WT

New America Acquisition I Corp. WT

$0.43+$0.05

+13.9%

ETSS.WT

Energy Transition Special Opportunities WT

$0.29+$0.03

+13.7%

SNYR

Synergy CHC Corp.Healthcare

$0.11+$0.02

+13.6%

NASDAQ · Mkt cap $1.6 M

The provided headlines mention InnovAge (INNV), not Synergy CHC (SNYR), so no direct news catalyst is established for today's 13.55% gain in SNYR.

The single headline in the RSS feed concerns InnovAge Holding Corp., a different company entirely, and does not reference Synergy CHC Corp. or explain SNYR's move. Since no news specific to SNYR is available, the gain is likely driven by one of several common catalysts for micro-cap stocks trading at $0.11: a delayed press release or earnings report from SNYR itself that has not yet appeared in the RSS feed, short-squeeze or retail trading interest, technical bounce from oversold conditions, or sector-wide momentum in healthcare or related verticals. Without access to SNYR-specific news or structural details about the company's capital structure, float, or known catalysts, the cause remains opaque.

NCRA

Nocera Inc.Consumer Defensive

$1.86+$0.25

+13.4%

NASDAQ · Mkt cap $3.2 M

No news headlines were found in the last 48 hours to explain NCRA's 13.44% gain on September 10, 2026. The move likely reflects technical trading, delayed news absorption, or a micro-cap liquidity event rather than a specific corporate announcement.

Yahoo Finance returned no headlines for Nocera Inc. in the 48-hour window surrounding this gain, which means either no material news was released or the market delay in reporting prevented visibility. Nocera is a micro-cap traded on NASDAQ at $1.86, a price point and market capitalization that typically exhibit higher volatility and respond sensitively to thin trading volume. A 13.44% single-day move in this category of stock is not extraordinary in absolute terms but warrants explanation. Common catalysts for small-cap gainers without attributed news include short covering, retail options activity expiring in-the-money, delayed earnings or clinical trial results becoming visible to retail platforms, or rebalancing within penny-stock indices. Without news confirmation, any causal claim would be speculative.

BAFN

BayFirst Financial Corp.Financial Services

$8.44+$0.99

+13.3%

NASDAQ · Mkt cap $164 M

No news was found in the last 48 hours for BAFN, so the 13.29% gain cannot be directly attributed to a specific announced event. The move likely reflects technical buying, sector momentum in regional banks, or delayed market reaction to an earlier announcement.

The absence of recent headlines for BayFirst Financial Corp. makes direct attribution impossible. Regional bank stocks can be volatile and responsive to sector-wide movements, interest rate expectations, or changes in economic outlook that affect lending margins and deposit flows. A 13.29% single-day gain for a stock trading near $8.44 could reflect short-covering, options-related hedging unwinds, or accumulated buying interest triggered by technical chart levels or a positive earnings surprise that was released more than 48 hours ago but only now gaining market attention. Without access to intraday catalysts or statements from the company, the true driver remains unclear, though regional financials are cyclically sensitive and can spike on improving credit conditions or dividend policy shifts.

CEIN

Camber Energy Inc

$0.03+$0.00

+12.8%

ALPXR

Alpex Acquisition Corporation Rights

$0.18+$0.02

+12.5%

BNC

CEA Industries Inc.Industrials

$4.98+$0.55

+12.4%

NASDAQ · Mkt cap $108 M

No news headlines were available in the last 48 hours to explain BNC's +12.44% gain, so the driver remains unclear without additional market context or corporate announcements.

CEA Industries (BNC) posted a significant one-day gain of 12.44%, ranking it among the top 50 gainers on NASDAQ, yet no news was indexed in the Yahoo Finance RSS feed during the relevant 48-hour window. This absence of documented headlines makes causal attribution difficult. For a micro-cap or thinly-traded stock like this, upward moves of this magnitude can be triggered by several mechanisms: delayed or unindexed press releases (earnings results, partnership announcements, or regulatory clearances), technical rebounds after oversold conditions, short covering, or rumors circulating in retail or message-board communities that precede formal announcements. Without verifiable event data, pinpointing the specific catalyst is not possible from the evidence at hand.

HCWC

Healthy Choice Wellness Corp.Consumer Defensive

$9.64+$1.05

+12.2%

NYSE · Mkt cap $7.4 M

The single headline provided discusses the data center market reaching $517 billion by 2030, but it contains no mention of HCWC and appears unrelated to a wellness company. The 12.22% gain lacks a clear news catalyst in the provided data.

The headline about global data center market growth is a generic industry forecast that makes no reference to Healthy Choice Wellness Corp. and appears to be commentary on the broader tech infrastructure sector rather than healthcare or wellness. There is a meaningful disconnect between the stock's strong gain and the available news. Without additional headlines or context, the catalyst for this move could stem from several categories: an unrelated positive earnings announcement or guidance raise from HCWC itself that simply was not captured in the Yahoo Finance RSS feed provided, a sector-wide tailwind in healthcare or wellness stocks, technical buying or short covering, or a company-specific announcement made through other channels not reflected here. Wellness companies sometimes respond to clinical trial results, regulatory approvals, or partnership news that might explain an intraday rally of this magnitude.

SUPX

Super X AI Technology LimitedTechnology

$8.23+$0.81

+11.2%

NASDAQ · Mkt cap $283 M

SuperX announced progress on its share repurchase program on September 9th, signaling management confidence in long-term value and likely driving the 11.19% gain as investors responded positively to the buyback commitment.

The headline from September 9th explicitly states that SuperX announced an update on its share repurchase program to demonstrate confidence in long-term growth value. Share buyback announcements typically signal that management believes the stock is undervalued and can be a positive catalyst for equity markets, as they reduce share count and can improve per-share metrics. The timing of this announcement on September 9th aligns directly with the stock's significant one-day gain on September 10th. The company is positioned as a full-stack AI infrastructure solutions provider, a sector that has attracted considerable investor interest. While the news excerpt is truncated and lacks specific details about repurchase size or timeline, the fundamental signal of management confidence appears sufficient to explain the intraday momentum.

FGI

FGI Industries Ltd.Consumer Cyclical

$8.34+$0.83

+11.1%

NASDAQ · Mkt cap $18 M

No news headlines were found in the last 48 hours, so the 11.05% gain on FGI likely reflects either delayed market reaction to an earlier announcement, technical trading, or an unreported catalyst.

The absence of any Yahoo Finance headlines in the 48-hour window makes it impossible to identify a specific news-driven cause for the 11.05% surge that placed FGI as the 50th biggest gainer on the day. Several plausible scenarios exist but remain speculative without additional information. The move could reflect delayed market digestion of an announcement that occurred more than 48 hours ago, a technical rebound after prior weakness, short covering, or an event that occurred but was not yet captured in the RSS feed used here. For a small-cap or micro-cap industrial company, institutional accumulation, analyst coverage initiation, or insider activity can sometimes drive outsized moves with minimal headline coverage. Without access to broader market context or intraday trading data, the true catalyst remains unknown.

Biggest Losers

Thu, Sep 10, 2026 50

GPAC

Global Partner Acquisition Corp IIFinancial Services

$0.17−$9.89

-98.3%

NASDAQ · Mkt cap $295 M

No news headlines are available in the last 48 hours to explain GPAC's catastrophic 98.31% decline, making the root cause unknown based on available information.

The complete absence of news in the provided headline feed is noteworthy given the severity of the move. GPAC is a special purpose acquisition company, a structure that typically experiences sharp moves tied to merger announcements, deal terminations, shareholder votes, or redemption events. A decline of this magnitude could reflect a failed or terminated merger, a significant redemption of shareholder shares, or the announcement of unfavorable deal terms. Alternatively, the stock could be experiencing a delisting warning or trading suspension, which would explain both the dramatic price collapse and the lack of contemporaneous news coverage. Without explicit reporting, any specific cause remains speculation, though SPAC-related events (merger failure, adverse regulatory development, or shareholder action) remain the most plausible category.

CETU

Cetus Capital Acquisition Corp. - Class A Common Stock

$5.10−$4.81

-48.5%

MKDW

MKDWELL Tech Inc. Ordinary Share

$5.16−$4.76

-48.0%

DICE

DICE Therapeutics, Inc.

$24.84−$22.71

-47.8%

SWRD

Stewards, Inc

$2.22−$1.99

-47.3%

HCAI

Hauchen AI Parking Management Technology Holding Co., Ltd. Ordinary SharesIndustrials

$2.47−$1.99

-44.1%

NASDAQ · Mkt cap $7.9 M

HCAI fell 44% despite announcing a strategic cooperation agreement with Beyinda Limited to expand metal components manufacturing in China; the severe drop suggests either broad microcap selling pressure, negative context outside the headline, or market skepticism about the partnership's near-term…

The only recent headline is a strategic cooperation announcement between HCAI and Beyinda Limited to expand precision metal components for new energy vehicles and related industrial applications in China. On the surface, a partnership announcement should be neutral to positive. However, a 44% single-day crash in a microcap stock rarely aligns with routine business development news. The disconnect suggests either context missing from the headline (e.g., shareholder dilution embedded in the deal, disappointing financial results released concurrently, or adverse regulatory news), broad-market selloff in the microcap or Chinese stock space, or market sentiment that the partnership lacks strategic substance. Without additional financial or regulatory detail, the cause remains unclear, though the magnitude points to either material negative information not reflected in this headline or severe technical/sentiment factors unrelated to the cooperation itself.

LHSW

Lianhe Sowell International Group Ltd Ordinary SharesTechnology

$0.66−$0.44

-41.2%

NASDAQ · Mkt cap $9.6 M

No news headlines were found in the last 48 hours, so the 41% drop cannot be attributed to reported events; this magnitude of decline in a micro-cap stock typically reflects either delayed bad news, technical selling, or market-wide liquidity pressure.

The absence of recent news headlines is notable given the severity of the price decline. LHSW is a micro-cap stock trading at $0.66, a price point where liquidity is thin and individual transactions can move the stock sharply. A 41% single-day loss in this range could reflect several common patterns: delayed disclosure of negative developments, insider selling, mass liquidation by a holder, delisting risk or compliance warnings, sector-wide margin calls, or technical breakdown below support levels that triggers algorithmic selling. Without access to news from before the 48-hour window or intra-day events that may not have been widely reported, the specific trigger cannot be determined from the evidence provided.

CDT

Conduit Pharmaceuticals IncHealthcare

$0.34−$0.24

-41.1%

ROC

ROC Energy Acquisition Corp.

$2.60−$1.74

-40.1%

NASDAQ · Mkt cap $83 M

No news headlines were found in the last 48 hours, so the 40% single-day drop cannot be directly attributed to a disclosed event. The decline likely reflects a sudden shift in market sentiment, technical selling, or an undisclosed development not yet captured in financial media.

ROC Energy Acquisition Corp. is a SPAC, a vehicle designed to identify and merge with an operating company. SPACs are highly sensitive to redemption risk, trust account depletion concerns, deal timeline uncertainty, and shifts in sponsor credibility or deal terms. A 40% single-day plunge without accompanying headlines suggests either a technical trigger such as a key deadline passing, unexpected redemptions, a deal announcement viewed negatively by the market, or a rumor circulating on social media or trading forums not yet reflected in traditional news outlets. SPACs also experience sharp moves tied to broader capital markets stress or changes in regulatory outlook. Without headline evidence, the specific catalyst remains unclear.

LEXX

Lexaria Bioscience Corp.Healthcare

$4.09−$2.33

-36.3%

NASDAQ · Mkt cap $19 M

Lexaria announced a warrant exercise closing that raised $5.9 million, a modest capital event that likely triggered profit-taking or highlighted cash constraints, causing the 36% single-day plunge on a small-cap biotech stock.

The only headline available announces the closing of a warrant exercise that generated approximately $5.9 million in gross proceeds. On its surface, this is a routine corporate action—companies routinely exercise warrants to raise capital. However, for a small-cap biotech trading near $4, a warrant exercise announcement can signal several concerns to the market: potential dilution to existing shareholders, investor skepticism about the company's ability to fund operations through other means, or simply a trigger for profit-taking in a volatile micro-cap name. The timing of the announcement on September 9 with the stock crashing 36% on September 10 suggests the market reacted negatively to either the news itself or to something else that emerged overnight. Without additional context on the company's cash position, burn rate, or previous dilution history, we cannot definitively rule out that this warrant exercise revealed more fundamental weakness than a typical capital raise would suggest.

SKIL

Skillsoft Corp.Consumer Defensive

$4.20−$2.10

-33.3%

NYSE · Mkt cap $71 M

Skillsoft crashed 33% despite beating earnings and posting margin gains, driven by full-year guidance trim due to consumer AI disruption offsetting enterprise stabilization.

Skillsoft reported Q2 fiscal 2027 earnings that beat expectations by nearly 41% and delivered strong operational metrics including 34% adjusted EBITDA margins and 7% EBITDA growth. However, the company simultaneously trimmed full-year guidance, citing weakness in its consumer business from AI disruption. Revenue declined 2.9% year-over-year to $98.2 million. The stock's 33% plunge reflects a classic forward-guidance miss: despite near-term profitability gains in the enterprise segment, investors are pricing in sustained consumer headwinds that the company now expects to persist. The same-day announcement of LX Design Studio, an AI content tool, appears insufficient to offset the guidance reduction. The market is clearly weighing the guidance cut and consumer weakness more heavily than the margin improvements and enterprise stabilization.

ALP

Alpha Compute CorpFinancial Services

$3.71−$1.78

-32.4%

NASDAQ · Mkt cap $4.1 M

Alpha Compute announced a major platform relaunch and secured $47 million in seller financing for a data center expansion, but the stock still fell 32%, suggesting investor skepticism about the company's capital structure, ability to execute, or valuation relative to the financing terms.

The two headlines describe what appear to be positive developments: a strategic pivot of the ALT/X platform toward the AI infrastructure market and secured financing that reduces upfront cash requirements from $55 million to $8 million at closing. However, a 32% single-day drop despite these announcements suggests the market interpreted these as negative signals. Possible explanations include concern that the seller financing arrangement signals weakness in the company's cash position or creditworthiness, doubt about the business model pivot's viability, or a reassessment of the company's path to profitability. The relaunch could also imply that the previous product strategy failed. Without earnings data, analyst downgrades, or explicit guidance changes in the headlines, the exact cause remains unclear, but the magnitude of the decline suggests structural concern rather than a minor tactical disappointment.

HUBC

Hub Cyber Security Ltd. - Ordinary SharesTechnology

$0.41−$0.19

-32.0%

NASDAQ · Mkt cap $23 M

Hub Cyber Security announced a reverse share split on September 10, 2026, which typically signals financial distress or a bid to regain compliance with exchange listing standards and likely triggered the 32% single-day loss.

The headline confirms that HUB Security announced a reverse share split on the same day as the 31.97% price decline. Reverse splits are commonly used by companies facing delisting risk due to falling below minimum price thresholds, to consolidate shareholder equity, or to improve the appearance of share price for institutional investors. While the full details of the split ratio and rationale are not provided in the truncated headline, the timing of the announcement coinciding with the sharp drop suggests market participants either anticipated negative details within the full announcement, view the reverse split as a red flag for underlying business weakness, or are selling in anticipation of further dilution or restructuring. The magnitude of the loss indicates this was a material negative catalyst rather than routine corporate housekeeping.

BENF

BeneficientFinancial Services

$1.21−$0.48

-28.3%

NASDAQ · Mkt cap $33 M

No news headlines were found in the last 48 hours to explain BENF's 28.3% single-day drop, making the immediate trigger unclear without additional reporting.

The absence of any Yahoo Finance headlines in the 48-hour window preceding this sharp decline means the direct catalyst is not established in the provided evidence. A stock drop of this magnitude typically reflects either negative company-specific news (earnings miss, guidance cut, executive departure, litigation), sector-wide pressure, or market microstructure factors like short covering reversals or forced liquidations. For a microcap stock trading at $1.21, liquidity constraints can amplify intraday moves substantially. Without access to press releases, SEC filings, earnings reports, or news coverage that may have been published before the snapshot window or announced after market close on the prior day, it is impossible to pinpoint whether this was driven by fundamentals, technical factors, or external events.

MGN

Megan Holdings LimitedIndustrials

$0.20−$0.07

-25.1%

NASDAQ · Mkt cap $3.7 M

No news headlines were found in the last 48 hours, so the 25% intraday drop cannot be attributed to a specific disclosed event. The decline is likely driven by technical selling, sector headwinds, or unannounced developments not yet captured by major news feeds.

The absence of any recent news makes it impossible to pinpoint a concrete catalyst for MGN's sharp 25% loss. For a micro-cap stock trading at $0.20, typical drivers of sudden declines include forced selling from margin calls or fund liquidations, deterioration in liquidity conditions, delayed earnings misses that take time to surface, insider selling, or deteriorating fundamentals not yet formally announced. Small-cap stocks are also more susceptible to technical breaks below key support levels and can be sensitive to broader sector rotations or index rebalancing that may not generate headline news. Without access to earnings calendars, SEC filings, or real-time trading halts, the specific trigger remains unknown but is most likely operational or technical rather than fundamental news-driven.

TRIS

Tristar Acquisition I Corp.

$0.30−$0.10

-24.4%

TWG

Top Wealth Group Holding Limited Ordinary SharesConsumer Defensive

$0.38−$0.12

-24.2%

NASDAQ · Mkt cap $22 M

No news headlines were published in the last 48 hours for TWG, so the 24% drop cannot be directly attributed to a reported event. The decline likely reflects either technical selling pressure, delayed news digestion, or broader market headwinds affecting micro-cap stocks.

The absence of recent news makes it impossible to pinpoint a specific catalyst for the sharp 24% decline in TWG shares. For a micro-cap stock trading at $0.38 on NASDAQ, price movements of this magnitude can occur due to several common drivers: thin liquidity causing outsized moves on modest volume, technical breakdown of support levels triggering automated selling, delayed market reaction to news released beyond the 48-hour window, or negative developments announced through non-traditional channels not captured by major news feeds. Additionally, micro-cap and penny stocks are often subject to broader sector rotation, short covering or short selling pressure, or changes in fund weightings that affect them disproportionately. Without corroborating headlines or structural information about TWG's recent announcements or financial status, attribution remains speculative rather than grounded in documented fact.

TONT.WT

Graf Global Corp.

$0.37−$0.11

-23.2%

VNCE

Vince Holding CorpConsumer Cyclical

$5.01−$1.35

-21.2%

NYSE · Mkt cap $81 M

Vince reported a strong Q2 earnings beat, raised full-year guidance, and announced a bold OVO acquisition strategy, yet the stock fell 21%, suggesting market concern about execution risk, acquisition integration costs, or valuation despite positive near-term results.

The headlines establish that VNCE delivered a significant earnings beat (277.78% earnings surprise), beat revenue estimates, achieved $18 million adjusted EBITDA, and raised full-year guidance—all traditionally positive catalysts. The company also outlined expansion plans for its newly acquired OVO streetwear brand through U.S. wholesale. Despite this fundamentally positive news flow, the stock declined 21%, ranking as the 19th biggest loser of the day. This disconnect suggests the market is pricing in concerns about the OVO acquisition's integration complexity, near-term margin pressure from expansion spending, uncertainty around wholesale channel execution for a streetwear brand, or a reassessment of valuation multiples even with improved guidance. Alternatively, the market may have had outsized bullish expectations beforehand that even a strong beat failed to meet, or there could be sector-wide or macro headwinds affecting apparel retail stocks on this date.

USDEW

StablecoinX Inc. Warrants

$1.50−$0.40

-21.0%

SLBT

SL Science Holding LimitedHealthcare

$2.07−$0.54

-20.7%

NASDAQ · Mkt cap $1.8 B

No news headlines are available in the last 48 hours to explain SLBT's sharp 20.69% drop, so the cause remains unclear without additional context or real-time market data.

The absence of any news in the provided Yahoo Finance RSS feed over the last 48 hours means there is no headline-driven catalyst we can point to for today's decline. SLBT is a small-cap holding company traded on NASDAQ, and stocks in this category can experience significant single-day swings for several reasons unrelated to public announcements: sharp technical reversals, sector-wide selloffs, delayed disclosure of negative developments, insider transactions, or shifts in sentiment within a thinly-traded name. Without access to intraday news wires, regulatory filings, or real-time social sentiment, we cannot identify whether this move stems from company-specific bad news, market structure (e.g., margin calls or short covering), or broader momentum trading. The magnitude of the loss (top 21 losers) suggests something material, but the headline vacuum leaves the specific catalyst unknown.

NXXT

EzFill Holdings, Inc.Utilities

$0.15−$0.04

-20.6%

NASDAQ · Mkt cap $40 M

NextNRG announced a 1-for-10 reverse stock split, which mechanically lowered the nominal share price and likely triggered selling pressure typical of reverse splits, contributing to the 20.61% decline.

The headline confirms NextNRG (ticker NXXT) announced a reverse stock split at a 1-for-10 ratio on September 10, 2026. Reverse splits are typically viewed negatively by markets because they signal financial distress, dilution concerns, or an attempt to meet exchange listing minimums. While the split itself is mechanical and does not change shareholders' proportional ownership, the announcement often triggers sell-offs as investors perceive it as a negative signal. The stock price of $0.15 after the split suggests it was trading around $0.015 before the announcement, consistent with a distressed micro-cap. The 20.61% single-day decline aligns with typical market reactions to reverse split announcements, though we cannot rule out concurrent negative sentiment or other factors not mentioned in the provided headlines.

FGL

Founder Group Limited Ordinary SharesIndustrials

$5.22−$1.30

-20.3%

NASDAQ · Mkt cap $475 K

No news headlines were found in the last 48 hours, so the 20% drop cannot be attributed to a specific disclosed event; the cause likely stems from technical selling, sector weakness, or an undisclosed development.

FGL experienced a sharp 20.31% single-day decline with zero news coverage in the prior 48 hours on Yahoo Finance RSS. This absence of headline correlation makes causality difficult to establish. The move could reflect several non-news-driven categories: technical breakdown or profit-taking after a prior run, broader market sector weakness affecting small-cap equities, trading halt resolution or delayed information dissemination not yet captured in RSS feeds, or a significant private development (guidance warning, insider transaction, or legal matter) that had not yet reached public disclosure at the snapshot time. Without structural insight into FGL's business model, capital structure, or known catalyst calendar, we cannot narrow this further.

BNAI

DHC Acquisition Corp.Technology

$8.23−$2.04

-19.8%

NASDAQ · Mkt cap $120 M

BNAI dropped 19.82% on September 10, but the only recent news is a positive announcement on September 8 about Cataneo's participation in IBC2026; no negative catalyst is evident in the provided headlines.

The available news headline from September 8 describes Cataneo (a division of Brand Engagement Network, Inc./BNAI) announcing participation in a major international exhibition in Amsterdam. This is typically neutral to modestly positive corporate visibility news and does not explain a 19.82% single-day loss. The timing gap between the announcement (September 8) and the price action (September 10) is notable; the stock may have reacted to unrelated market conditions, technical selling pressure, sector-wide declines in AI or software stocks, or negative news not captured in the provided RSS feed. BNAI is a SPAC-affiliated entity (DHC Acquisition Corp.), which can exhibit volatile trading independent of fundamentals. Without additional headlines covering earnings misses, insider sales, sector rotation, or technical support breaks, the specific trigger for this 24th-largest daily loss cannot be pinpointed from the evidence provided.

SUNE

Pineapple Energy Inc.Technology

$3.36−$0.76

-19.5%

NASDAQ · Mkt cap $9.2 M

Pineapple Energy (SUNE) fell 19.54% on September 10, likely reversing gains from a September 9 rally that followed news of Suniva's $835 million capital raise for solar manufacturing expansion.

On September 8–9, markets reacted positively to Suniva's announcement of an $835 million capital raise to build a second U.S. solar cell manufacturing facility and quadruple capacity to 5.5 GW. SUNE jumped nearly 26% in premarket trading on September 9, suggesting investor optimism about solar manufacturing growth and U.S. policy tailwinds. The September 10 decline of 19.54% appears to be a partial or full reversal of that gain. This could reflect profit-taking after a sharp single-day jump, reassessment of the actual impact on SUNE's earnings or cash position, or market rotation away from the solar sector. The headlines establish the positive catalyst but do not explain the subsequent reversal, which is common after volatile one-day rallies.

GCDT

Green Circle Decarbonize Technology LimitedIndustrials

$0.53−$0.13

-19.1%

NYSE · Mkt cap $5.2 M

No news headlines were found in the last 48 hours to explain the 19.15% drop, making the cause unclear without additional context or market information.

GCDT fell 19.15% to $0.53 on September 10, 2026, with no recent news headlines available to account for the move. At this price level and given the lack of reported catalysts, the drop could reflect several common drivers for microcap or distressed securities: profit-taking after a prior rally, technical breakdown through key support levels, broader sector rotation away from green energy or decarbonization plays, dilutive equity issuance announced after market close or via SEC filing not yet captured in news feeds, deteriorating fundamentals reflected in updated analyst coverage, or simply low-liquidity dynamics amplifying a modest sell-off. Without access to company-specific developments, recent filings, or intraday news flow, attribution remains speculative.

BEAGR

Bold Eagle Acquisition Corp. Right

$0.25−$0.05

-18.8%

NASDAQ

No news headlines were found in the last 48 hours, so the 18.76% decline cannot be attributed to a specific disclosed event; the drop likely reflects technical selling, broad market conditions, or undisclosed corporate developments typical of SPAC right securities.

Bold Eagle Acquisition Corp. Right (BEAGR) experienced a significant single-day loss with no supporting headlines in the immediate news cycle. This security is a SPAC rights offering, a specialized instrument that typically trades at lower prices and with higher volatility than the underlying warrant or common shares. Rights offerings commonly face pressure from dilution concerns, redemption announcements, or deteriorating sentiment toward the underlying acquisition target or SPAC structure itself. Without headline confirmation, the decline could stem from technical factors such as profit-taking after a prior rally, forced liquidations in SPAC-focused portfolios, or late-breaking news that has not yet propagated to major financial news feeds. Broader market weakness or sector rotation away from blank-check companies could also explain the move.

NRSN

NeuroSense Therapeutics Ltd.Healthcare

$0.34−$0.08

-18.6%

NASDAQ · Mkt cap $14 M

The provided headline announces a presentation at an investment conference, which is routine business development news that would not typically trigger an 18.56% single-day drop; the decline likely stems from other market factors not reflected in the available news.

The only news headline provided is a routine announcement that NeuroSense will present at the H.C. Wainwright investment conference, which is standard promotional activity for biotech companies and would not explain a nearly 19% intraday loss. This type of announcement is generally neutral to mildly positive for investor relations. The large single-day decline suggests either unreported news occurred between the snapshot date and market close, broader market sell-off in biotech or small-cap stocks, or a sector-specific catalyst affecting clinical-stage neurodegenerative disease companies. For a late-stage biotech stock trading at $0.34, common drivers of sharp drops include clinical trial setbacks, regulatory rejection letters, significant insider selling, or delisting warnings, none of which appear in the available headlines.

AIFU

Fanhua Inc.Financial Services

$12.41−$2.80

-18.4%

NASDAQ · Mkt cap $74 M

No news headlines were found in the last 48 hours for AIFU, so the 18.39% drop cannot be attributed to a specific announced event. The decline may reflect technical selling, broader market pressure, or untracked developments.

The absence of recent news headlines makes it impossible to pin the move to a concrete catalyst. AIFU is Fanhua Inc., a Chinese online education and career services platform, which means it could be sensitive to regulatory announcements from China, changes in education policy, or shifts in investor sentiment toward the Chinese tech sector. Alternatively, the move could stem from technical factors such as stop-loss selling, options expiration dynamics, or a delayed market reaction to news not captured in the 48-hour window. Without a specific headline or structural insight tied to this particular security, the precise cause remains speculative.

APMCR

AmperCap Acquisition Company Right

$0.09−$0.02

-18.2%

NASDAQ

No news was found in the last 48 hours to explain the 18% drop in APMCR. The decline likely reflects either general warrant/right deterioration as the underlying SPAC winds down, a delayed market reaction to an earlier announcement, or routine volatility in micro-cap SPAC securities.

AmperCap Acquisition Company Right (APMCR) is a SPAC warrant or rights offering, which by structure are highly volatile and time-sensitive instruments with diminishing intrinsic value as redemption or merger deadlines approach. The absence of any news headline in the last 48 hours does not rule out a catalyst; the drop could reflect a delayed market reaction to news from earlier in the week, updated sponsor communications, or a redemption/extension deadline passing. SPAC right and warrant holders often face significant value erosion absent a successful merger announcement. Another possibility is that the underlying SPAC announced an unfavorable deal or news broke regarding merger prospects. Without recent headlines, the primary inference is structural: warrant and right positions naturally decay over time, and large single-day moves in these securities are common and often driven by micro-cap liquidity constraints or expiration mechanics rather than broadly reported catalysts.

BBOT

BridgeBio Oncology Therapeutics, Inc.

$5.51−$1.20

-17.7%

MOVE

Movano Inc.Technology

$11.54−$2.43

-17.4%

NASDAQ · Mkt cap $11 M

MOVE dropped 17.39% on September 10 with no news headlines in the last 48 hours, making the specific catalyst unclear and suggesting either a delayed announcement, technical sell-off, or market-wide sector weakness.

No headlines appeared in the Yahoo Finance RSS feed within 48 hours of this sharp 17.39% decline, which eliminates immediate news-driven explanation. For a small-cap healthcare or medical device company like Movano, typical catalysts for large single-day drops include clinical trial results, regulatory setbacks, guidance reductions, insider selling disclosures, or short-seller reports. The lack of any captured headline does not rule out these events occurring; announcements may have been released outside the monitored feed window, via direct company channels, or through delayed reporting. Technical selling pressure, options expiration effects, or sector-wide biotech weakness could also drive such a move without company-specific news. Without access to real-time company disclosures, SEC filings, or full market data, the root cause remains speculative.

UZX

Linkage Global IncConsumer Cyclical

$0.09−$0.02

-17.1%

NASDAQ · Mkt cap $7.8 M

No news headlines were found in the last 48 hours for UZX, so the 17% drop likely reflects technical selling, sector weakness, or undisclosed news not yet indexed by Yahoo Finance.

The absence of recent news headlines makes it impossible to attribute UZX's sharp 17% decline to any specific corporate event such as earnings, guidance, or regulatory action. For a micro-cap stock trading at $0.09, several plausible drivers exist independent of news coverage. The stock may have experienced profit-taking after a prior run, margin calls forcing liquidation, or reaction to broader market or sector weakness that occurred intraday. Alternatively, the catalyst could be news released through channels not captured by the Yahoo Finance RSS feed, including company press releases, SEC filings, or social media. Without corroborating headlines or filing data, attribution remains speculative.

TWLVR

Twelve Seas Investment Company III Rights

$0.09−$0.02

-15.4%

NASDAQ

No news headlines appeared in the last 48 hours, but TWLVR is a SPAC rights offering security whose value is directly tied to the underlying warrant redemption mechanics and market sentiment toward special purpose acquisition vehicles, which have faced significant headwinds in 2026.

The absence of any news in the past 48 hours means this 15% daily decline cannot be traced to a company-specific announcement or event. However, TWLVR's structure as a rights offering for Twelve Seas Investment Company III provides important context. Rights securities are highly sensitive to the broader SPAC and blank-check market environment, which experienced substantial cooling in 2026 after years of excess issuance. Declines in this category of security typically reflect either sector-wide repricing (investors exiting SPAC positions broadly), deteriorating sentiment about the underlying acquisition target if one has been identified, or technical selling pressure within a thin, low-priced security. The 15% single-day drop for a sub-dollar rights offering is notable but not unusual for illiquid, leveraged vehicles in stressed market conditions.

NOMA

NOMADAR Corp.Consumer Cyclical

$1.69−$0.29

-15.3%

NASDAQ · Mkt cap $38 M

No news headlines were available in the past 48 hours to explain NOMA's 15.26% decline, so the catalyst remains unclear without additional context or intraday information.

The absence of any news in the Yahoo Finance RSS feed over the last 48 hours means we cannot point to a specific company announcement, earnings release, regulatory action, or market event as the direct cause of this sharp single-day drop. For a micro-cap or lower-liquidity stock trading near $1.69, declines of this magnitude can result from several categories of events: technical selling triggered by a breach of support levels, delayed negative news not yet reflected in major feeds, insider activity or SEC filings released outside standard channels, sector rotation, or shifts in sentiment around smaller-cap holdings. Without access to Level 2 data, company filings, social media discussion, or financial websites beyond the provided headlines, we cannot distinguish between these possibilities. The 15.26% drop is material enough to suggest a real event rather than random noise, but its nature is opaque from this data set alone.

SSM

Sono Group N.V.Consumer Cyclical

$1.99−$0.36

-15.1%

NASDAQ · Mkt cap $3.8 M

No news headlines were found in the last 48 hours to explain SSM's 15.13% drop, suggesting the decline may stem from broader market weakness, sector rotation, or undisclosed company developments not yet reflected in major news feeds.

Sono Group is a solar vehicle technology company that has faced significant headwinds since its NASDAQ listing, including production delays, capital constraints, and competitive pressures in the emerging solar automotive space. The absence of any news headlines in the last 48 hours indicates this particular 15% decline was not triggered by a discrete announced event such as earnings, guidance revision, partnership news, or regulatory action. For a speculative or distressed-stage company like SSM, daily moves of this magnitude can be driven by several categories of factors: technical selling or algorithmic repositioning following a technical breakdown, sector-wide pressure on clean-energy or EV-adjacent stocks, short covering reversals, margin calls, or thinly-veiled negative sentiment circulating in research channels or social media that precedes formal news publication. Without access to real-time social sentiment, trading volume analysis, or intraday catalyst reports, the specific trigger remains unclear.

COLA

Columbus Acquisition Corp Ordinary Shares

$8.30−$1.45

-14.9%

BHVN

Biohaven Pharmaceutical Holding Co Ltd

$12.78−$2.22

-14.8%

COO

Cooper Cos Inc-TheHealthcare

$54.23−$9.37

-14.7%

NASDAQ · Mkt cap $14 B

Cooper Companies missed Q3 revenue expectations due to U.S. channel destocking, cut full-year guidance, and failed to sell CooperSurgical at an attractive valuation, prompting a 14.7% stock decline despite beating EPS and generating record free cash flow.

The earnings report on September 10 revealed multiple headwinds that overshadowed operational positives. Cooper beat adjusted EPS estimates and achieved record free cash flow of $273 million, plus a $307 million tax benefit, but Q3 revenues fell short of Wall Street expectations. The primary driver was U.S. inventory destocking in the CooperVision contact lens business. More significantly, management announced it would retain CooperSurgical rather than sell it, disappointing investors who had anticipated monetizing the women's health and fertility unit. Bank of America noted the company could not secure an attractive valuation for CooperSurgical given competitive pressure. Additionally, management cut forward guidance for fiscal 2027, and analysts flagged increasingly challenging margin leverage ahead, citing limited near-term appeal. The combination of missed topline guidance cut and divestiture failure triggered widespread downgrades and sell-side pressure.

ASPU

Aspen Group Inc-COConsumer Defensive

$0.23−$0.04

-14.6%

NASDAQ · Mkt cap $7.6 M

No news headlines were available in the last 48 hours, so the 14.61% decline cannot be attributed to a specific announced event. The drop likely reflects either technical selling, broader market pressure, or undisclosed negative developments.

The absence of any news coverage in the Yahoo Finance RSS feed for ASPU over the past two days makes it impossible to tie the significant single-day decline to a concrete catalyst. Aspen Group is a small-cap educational services company trading at a very low price point of $0.23, which typically makes it susceptible to higher volatility and potentially lower analyst coverage. Possible explanations for this kind of move in a micro-cap stock include technical support levels breaking down, margin liquidations, delayed disclosure of poor business metrics or operational issues, or broader sector weakness in online education that hasn't yet surfaced in major headlines. Without access to intra-day trading patterns, insider activity, or company press releases outside the RSS feed, it is not possible to identify the specific cause.

MHLD

Maiden Holdings Ltd

$6.31−$1.06

-14.3%

AEO

American Eagle Outfitters IncConsumer Cyclical

$14.52−$2.39

-14.1%

NYSE · Mkt cap $2.9 B

American Eagle fell 14% after Q2 earnings that beat revenue and profit expectations but missed comparable sales forecasts, with investor concern centered on weakness at the namesake brand and reliance on a $161 million one-time tariff refund to inflate results.

The earnings release on September 9–10 revealed mixed underlying business health. While the company beat on absolute revenue and reported operating profit of $211 million, headlines emphasize that this profit figure was significantly boosted by a one-time tariff refund of $161 million, raising questions about normalized earning power. Most critically, comparable sales came in short of estimates, signaling traffic or pricing weakness. The namesake American Eagle brand showed particular strain with soft women's sales, though the Aerie subsidiary surged 25%. Investors appear to be punishing the stock not for missing earnings but for evidence that core retail demand is softer than expected and that reported profitability masks operational headwinds. The disconnect between headline earnings beat and comparable sales miss, combined with the material one-time item, has driven a repricing lower.

DDC

DDC Enterprise LimitedConsumer Defensive

$0.25−$0.04

-13.9%

NYSE · Mkt cap $27 M

No news headlines were found in the last 48 hours, so the 13.94% decline cannot be directly attributed to a specific announced event; the move likely reflects either technical selling pressure, delayed market reaction to older news, or sentiment shift in a micro-cap stock.

The absence of recent news within the 48-hour window makes it impossible to pinpoint a concrete catalyst for the sharp 13.94% drop in DDC Enterprise Limited. Given that DDC trades at $0.25 per share and ranked as the 43rd biggest loser on the day, this is a micro-cap security where price moves can be driven by factors other than headline news, including thin liquidity, retail trading activity, short covering, or broader sector weakness affecting small-cap enterprise software or technology firms. It is also possible that relevant news was released but has not yet been indexed in the RSS feed, or that the market is responding to information from before the 48-hour cutoff that has now had delayed impact. Without access to the company's recent announcements, earnings calendar, or insider activity, alternative explanations remain speculative.

PAII.WT

Pyrophyte Acquisition Corp. II WT

$0.31−$0.05

-13.9%

OSRH

Bellevue Life Sciences Acquisition Corp.Healthcare

$0.19−$0.03

-13.7%

NASDAQ · Mkt cap $21 M

No news was published in the last 48 hours explaining the 13.70% decline in OSRH, so the drop likely reflects broader market conditions, technical selling, or undisclosed private information about the SPAC or its pending merger.

Bellevue Life Sciences Acquisition Corp. is a blank-check company (SPAC) with a minimal trading price of $0.19, suggesting it may be near dissolution, in a failed merger process, or experiencing severe shareholder dilution. The absence of any recent headlines makes it impossible to pinpoint a specific corporate catalyst. For SPACs trading at distressed levels, typical drivers of sudden declines include expiration of merger deadlines, failed deal negotiations, insider selling, redemption waves, or general retail sell-offs on technical support breaks. Without news, the move could also reflect delayed market pricing of earlier announcements or shifts in SPAC sentiment broadly. The 45th-biggest-loser ranking indicates sector-wide pressure may not be the primary cause, pointing instead to stock-specific deterioration.

LAKE

Lakeland Industries Inc

$9.65−$1.53

-13.7%

LSTA

Lisata Therapeutics IncHealthcare

$1.65−$0.26

-13.6%

NASDAQ · Mkt cap $10 M

No news was found in the last 48 hours to explain the 13.61% drop in LSTA, suggesting the decline may be driven by technical selling, sector weakness, or an undisclosed development not yet reflected in major news feeds.

The absence of any headlines in the Yahoo Finance RSS feed over the past 48 hours means we cannot identify a specific catalyst for LSTA's sharp 13.61% decline. For a microcap biotech or therapeutics stock like Lisata, typical drivers of single-day drops of this magnitude include: disappointing clinical trial results or data presentations that may be reported through a company press release before reaching broader news aggregation; significant insider selling or a secondary offering announcement; sector-wide sell-offs affecting small-cap biotech names; or technical breakdown from heavy short interest. Without corroborating news, these remain hypotheses rather than explanations. It is also possible the move was driven by low trading volume amplifying normal fluctuations, or by a development that has not yet been widely indexed by news services.

RBOT

D8 Holdings Corp.Healthcare

$0.04−$0.01

-13.6%

NYSE · Mkt cap $257 K

No news headlines were found in the last 48 hours for RBOT, so the 13.56% decline likely reflects either a delayed market reaction to an earlier announcement, a technical or sector-wide sell-off, or breaking news not yet captured in the RSS feed.

The absence of recent headlines makes attribution difficult. RBOT is a micro-cap stock trading at $0.04, which typically exhibits high volatility and limited news coverage. Possible drivers include delayed negative earnings or financial results released outside the RSS monitoring window, a broader sell-off in penny stocks or the robotics sector, insider selling or dilution through secondary offerings, or market sentiment shifts tied to broader economic data. Without access to contemporaneous press releases, SEC filings, or real-time social media discussion, we cannot isolate a specific catalyst. The stock's rank as the 48th biggest loser suggests meaningful volume, which rules out pure illiquidity but does not pinpoint cause.

OLB

The OLB Group, Inc.

$0.29−$0.04

-13.4%

PRTS

US Auto Parts Network IncConsumer Cyclical

$8.67−$1.33

-13.3%

NASDAQ · Mkt cap $53 M

No news headlines were found in the last 48 hours, so the 13.3% decline in PRTS shares cannot be directly attributed to a disclosed event. The drop likely reflects broader market sentiment, technical selling, or unreported developments.

The absence of recent news headlines makes it impossible to identify a specific catalyst for the sharp 13.3% drop in US Auto Parts Network stock. This company operates in the auto parts retail sector, which is sensitive to consumer spending patterns, used vehicle prices, and broader economic conditions. A decline of this magnitude in a single day without accompanying headlines typically falls into a few categories: technical or algorithmic selling triggered by price levels or volume thresholds, a delayed market reaction to older news that resurfaced, short-seller activity or negative social media commentary that hasn't yet made mainstream financial press, or an earnings warning or insider transaction released outside the major news feeds. Without access to the underlying cause, attribution remains speculative.